Opinion|Videos|January 27, 2025
Exploring the Pediatric Patient and Caregiver Journey
Panelists discuss the patient journey for patients with pediatric atopic dermatitis (AD) and their caregivers, from initial presentation through to diagnosis, emphasizing the challenges and emotional aspects that families experience throughout the process.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Describe the patient journey for pediatric patients with AD and their caregivers from initial presentation to diagnosis.
Advertisement
Related to this article
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Oral icotrokinra kept PASI 90 rates at ≥72% and IGA 0/1 at ≥70% from week 64 to 112 in ICONIC-LEAD, with no new safety signals.
At AAP 2026, Justin Wheeler, MD, discussed bowel cleanouts, maintenance therapy, and behavioral strategies for managing constipation in children.
Justin Wheeler, MD, explains how pediatricians can identify constipation across age groups and distinguish overflow incontinence from diarrhea.
Nichole Tyson, MD, outlines how pediatricians can evaluate menstrual concerns, identify red flags, and determine when specialty care is needed.
At AAP 2026, Stephen Bondi, JD, MD, FAAP, outlined steps pediatricians should take after receiving notice of a malpractice claim.
Advertisement
Advertisement